To date limited information about cefiderocol use is provided by real life studies. Our aim is to evaluate characteristics and outcome of patients with Gram-negative infections with limited therapeutic options treated with cefiderocol in combination or monotherapy.
Cefiderocol use in Gram negative infections with limited therapeutic options: Is combination therapy the key?
Corcione, Silvia;De Benedetto, Ilaria;Pinna, Simone Mornese;Vita, Davide;Lupia, Tommaso;Montrucchio, Giorgia;Brazzi, Luca;De Rosa, Francesco Giuseppe
2022-01-01
Abstract
To date limited information about cefiderocol use is provided by real life studies. Our aim is to evaluate characteristics and outcome of patients with Gram-negative infections with limited therapeutic options treated with cefiderocol in combination or monotherapy.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
211 - 2022 Cefiderocol use - Corcione.pdf
Accesso riservato
Tipo di file:
PDF EDITORIALE
Dimensione
384.49 kB
Formato
Adobe PDF
|
384.49 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
